Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.
about
The challenge of stroke prevention with intracranial arterial stenosisBlood Pressure Management for Stroke Prevention and in Acute StrokeOutcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysisDo Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID?Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial.Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial.Simultaneous Bilateral Carotid Stenting for Symptomatic Bilateral High-Grade Carotid Stenosis: A Retrospective Clinical InvestigationThe Feinberg Award Lecture 2013: treatment of intracranial atherosclerosis: learning from the past and planning for the future.Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.Relationship between risk factor control and vascular events in the SAMMPRIS trial.Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial.Stroke Caused by Atherosclerosis of the Major Intracranial Arteries.Management of Symptomatic Intracranial Stenosis.Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis?Practical approach to management of intracranial atherosclerosis.
P2860
Q27010215-A4CA9327-407D-4E11-8CCE-B7C2B6A627C4Q33783596-5DC68D70-8F3B-4523-9AFC-A02482F6E422Q35126194-51DF39B3-2022-45B8-ADAA-30D0A8AB9CE0Q35998370-D9716FCD-C3AF-4202-9198-07FEC15F537CQ36219939-878B1C46-E804-403F-89FF-FB7AC5196D25Q36405866-FC2BFA2F-A6B5-4DC8-AA48-DB42FCDCD7B7Q36965972-22B5CF16-5365-4FF9-AC00-99B5D90CFA15Q37197698-5FEF5C59-C1D9-4A6A-9DB6-7D210B790B3EQ37276835-96221491-4DF4-41DA-B1E2-D250D865CB7BQ37677096-81A3B304-616D-4477-A615-C707A1A4ECCCQ37710110-303DABEA-5633-45C0-A343-429A5F741962Q38383226-8F48B7D0-A10C-4AF7-9D64-7FA588F2A71CQ38397492-C4F837C1-6352-4D02-9928-EBEA48E9ED83Q38762569-291BF852-50AA-4D09-815B-4C9968FFEAEAQ38904533-FE41ECBC-A192-4499-B482-2D0152B9DC73Q51074477-5B9244E1-38CE-4F8B-9964-41F70AB9EFEEQ53594397-548BC942-1338-4270-A070-E654D447EDC0
P2860
Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Rationale, design, and impleme ...... ial Stenosis (SAMMPRIS) trial.
@ast
Rationale, design, and impleme ...... ial Stenosis (SAMMPRIS) trial.
@en
type
label
Rationale, design, and impleme ...... ial Stenosis (SAMMPRIS) trial.
@ast
Rationale, design, and impleme ...... ial Stenosis (SAMMPRIS) trial.
@en
prefLabel
Rationale, design, and impleme ...... ial Stenosis (SAMMPRIS) trial.
@ast
Rationale, design, and impleme ...... ial Stenosis (SAMMPRIS) trial.
@en
P2093
P2860
P50
P1476
Rationale, design, and impleme ...... ial Stenosis (SAMMPRIS) trial.
@en
P2093
Andrew Stufflebean
Azhar Nizam
Brent M Egan
Carole L White
Kathie L Hermayer
Maria F Lopes-Virella
Meghan R Steiner
Michelle F Caskey
Nicole Vilardo
Oscar Benavente
P2860
P304
P356
10.1161/CIRCOUTCOMES.112.966911
P50
P577
2012-09-01T00:00:00Z